Psychogenic movement disorders: Diagnosis and management

CNS Drugs

Volumn 18, Issue 7, 2004, Pages 437-452

  Thomas, Madhavi ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; DOXEPIN; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; ISOCARBOXAZID; MAPROTILINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TERTIARY AMINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG;

ANXIETY DISORDER; COGNITIVE THERAPY; COMORBIDITY; CONVERSION DISORDER; DEPRESSION; DISEASE PREDISPOSITION; DOCTOR PATIENT RELATION; DYSKINESIA; DYSPHONIA; DYSTONIA; EVALUATION; FACTITIOUS DISEASE; GAIT DISORDER; HEMIFACIAL SPASM; HISTRIONIC PERSONALITY DISORDER; HUMAN; HYPNOSIS; MOTOR DYSFUNCTION; MUNCHAUSEN SYNDROME; MUNCHAUSEN SYNDROME BY PROXY; MYOCLONUS; ONSET AGE; PARKINSONISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SEIZURE; SEXUAL ABUSE; SOCIAL ASPECT; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; TREMOR;

ANXIETY; COMORBIDITY; DEPRESSION; FACTITIOUS DISORDERS; HUMANS; MOVEMENT DISORDERS; PROGNOSIS; PSYCHOPHYSIOLOGIC DISORDERS; RISK FACTORS; SOMATOFORM DISORDERS;

EID: 2942577858     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200418070-00003     Document Type: Review

References (83)

1. Lewis A. "Psychogenic": a word and its mutations. Psychol Med 1972; 2: 209-15
2. Stone J, Zeman A, Sharpe M. Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2002; 73: 241-5
3. Charcot JM. Clinical lectures on diseases of the nervous system. London: The New Sydenham Society, 1877-89
4. Cowers WR. A manual of diseases of the nervous system. Hafner: Darion, 1893. Reprinted 1970
5. Head HH. The diagnosis of hysteria. BMJ 1922; 1: 827-9
6. Marsden CD. Hysteria- a neurologist's view. Psychol Med 1986; 16: 277-88
7. Trimble MR. Neuropsychiatry. Chichester (NY): John Wiley & Sons, 1981: 79-87
8. Lempert T, Diettrich M, Huppert D, et al. Psychogenic disorders in neurology: frequency and clinical spectrum. Acta Neurol Scand 1990; 82: 335-40
9. Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile and characteristics. J Neurol Neurosurg Psychiatry 1995; 59: 409-12
10. Slater E. Diagnosis of 'hysteria'. BMJ 1965; 1: 1395-9
11. Whitlock FA. The aetiolgy of hysteria. Acta Psychiatr Scand 1967; 43: 144-62
12. Merskey H, Buhrich NA. Hysteria and organic brain disease. Br J Med Psychol 1975; 48: 359-66
13. Ranawaya R, Riley D, Lang AE. Psychogenic dyskinesias in patients with organic movement disorders. Mov Disord 1990; 5: 127-33
14. Krumholz A, Niedermeyer E. Psychogenic seizures: a clinical study with follow up data. Neurology 1983; 33: 498-502
15. Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol 1995; 65: 231-57
16. Zeigler FJ, Imboden JB, Meyer E. Contemporary conversion reactions: a clinical study. Am J Psychiatry 1960; 116: 901-10
17. Servan-Schreiber D, Kolb R, Tabas G. Mental health: the somatizing patient. Prim Care 1999; 26: 226-42
18. Barsky AJ, Wyshak G, Klerman GL. Psychiatric co-morbidity in DSM-III-R hypochondriasis. Arch Gen Psychiatry 1992; 49: 101-8
19. Wise MG, Ford CV. Factitious disorders. Prim Care 1999; 26: 315-26
20. Turner J, Reid S. Muchausen's syndrome. Lancet 2002; 359: 346-9
21. Meadow R. Munchausen syndrome by proxy: the hinterland of child abuse. Lancet 1977; II: 343-5
22. Feinstein A, Stergiopoulos V, Lang AE. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 169-76
23. Vuilleumier P, Chicherio C, Assal F, et al. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain 2001; 124: 1077-90
24. Purtell JJ, Robins E, Cohen ME. Observations in clinical aspects of hysteria: a quantitative study of 50 hysteria patients and 150 control subjects. JAMA 1951; 146: 902-9
25. Ron M. Explaining the unexplained: understanding hysteria. Brain 2001; 124: 1065-6
26. Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol 1988; 50: 431-55
27. Marjama J. Troster AI, Koller WC. Psychogenic movement disorders. Neurol Clin 1995; 13: 283-97
28. Kurlan R, Brin MF, Fahn S. Movement disorder in reflex sympathetic dystrophy: a case proven to be psychogenic by surveillance video monitoring. Mov Disord 1997; 12: 243-5
29. Walters AS, McHale D, Sage JI, et al. A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-Dopa-induced chorea. Clin Neuropharmacol 1990; 13: 236-40
30. Lang AE. Psychogenic dystonia: a review of 18 cases. Can J Neurol Sci 1995; 22: 136-43
31. Koller WC, Lang AE, Vetere-Overfield B, et al. Psychogenic tremors. Neurology 1989; 39: 1094-9
32. Deuschl G, Koster B, Lucking C, et al. Diagnostic and pathophysiological aspects of psychogenic tremors. Mov Disord 1998; 13: 294-302
33. Kim YJ, Anthony S, Pakiam I, et al. Historical and clinical features of psychogenic tremor: a review of 70 cases. Can J Neurol Sci 1999; 26: 190-5
34. Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord 2002; 17: 726-34
35. Bressman SB, Fahn S, Burke RE. Paroxysmal non-kinesigenic dystonia. Adv Neurol 1988; 50: 403-13
36. Lang AE, Koller WC, Fahn S. Psychogenic Parkinsonism. Arch Neurol 1995; 52: 802-10
37. Knapp PC. Astasia-abasia, with report of a case of paroxysmal trepidant abasia, associated with paralysis agitans. J Nerv Ment Dis 1891; 17: 673-703
38. Spiller WG. Akinesia algera. Arch Neurol Psych 1933; 30: 842-84
39. Southard EE. Shell-shock and other neuropsychiatric problems. Boston: WM Leonard, 1919
40. Oppenheim H. Diseases of the nervous system. 1st ed. Philadelphia: JB Lippincott, 1900: 803
41. Keane JR. Hysterical gait disorders: 60 cases. Neurology 1989; 39: 586-9
42. Lempert T, Brandt T, Dietrich M, et al. How to identify psychogenic disorders of stance and gait: a video study in 37 patients. J Neurol 1991; 238: 140-6
43. Hayes MW, Graham S, Heldorf P, et al. A video review of the diagnosis of psychogenic gait: appendix and commentary. Mov Disord 1999; 14: 914-21
44. Tan EK, Jankovic J. Psychogenic hemifacial spasm. J Neuropsychiatry Clin Neurosci 2001; 13: 380-4
45. Leonard R, Kendall K. Differentiation of spasmodic and psychogenic dysphonias with phonoscopic evaluation. Laryngoscope 1999; 109: 295-300
46. Monday K, Jankovic J. Psychogenic myoclonus. Neurology 1993; 43: 349-52
47. Eldridge R, Riklan M, Cooper IS. The limited role of psychotherapy in torsion dystonia. experience with 44 cases. JAMA 1969; 210: 705-8
48. Marsden CD, Harrison MJG. Idiopathic torsion dystonia. Brain 1974; 97: 793-810
49. Cooper LS, Cullinan T, Riklan M. The natural history of dystonia. Adv Neurol 1976; 14: 157-69
50. Lesser RP, Fahn S. Dystonia: a disorder often misdiagnosed as a conversion reaction. Am J Psychiatry 1978; 153: 349-452
51. Ferraz HB, Andrade AF. Symptomatic dystonia: clinical profile of 46 Brazilian patients. Can J Neurol Sci 1992; 19: 504-7
52. Jayne D, Lees AJ, Stern GM. Remission in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1984; 47: 1236-7
53. Friedman A, Fahn S. Spontaneous remissions in spasmodic torticollis. Neurology 1986; 36: 398-400
54. Neng T, Yi C, Xiu-Bao Z, et al. Acute infectious torticollis. Neurology 1983; 33: 1344-6
55. Blakeley J, Jankovic J. Secondary causes of paroxysmal dyskinesia. Adv Neurol 2002; 89: 401-20
56. Fletcher NA, Harding AE, Marsden CD. A case controlled study of idopathic torsion dystonia. Mov Disord 1991; 6: 304-9
57. Jankovic J, Van Der Linden C. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry 1988; 51: 1512-9
58. Jankovic J. Can peripheral trauma induce dystonia and other movement disorders? Yes! Mov Disord 2001; 16: 7-12
59. Jankovic J. Post-traumatic movement disorders: central and peripheral mechanisms. Neurology 1994; 44: 2008-14
60. Bhatia KP, Bhatt MH, Marsden CD. The causalgia-dystonia syndrome. Brain 1993; 116: 843-51
61. Schwartzman RJ, Kerrigan J. The movement disorder of reflex sympathetic dystrophy. Neurology 1990; 40: 57-61
62. Lang AE, Fahn S. Movement Disorder of RSD [letter to the editor]. Neurology 1990; 40: 1476
63. Gower WR. Diseases of the nervous system. Philadelphia: Blackston, Son & Co, 1888
64. Campbell J. The shortest paper. Neurology 1979; 29: 1633
65. Walters AS, Hening W. Noise-induced psychogenic tremor associated with post traumatic stress disorder. Mov Disord 1992; 7: 333-8
66. O'Sulleabhain PE, Matsumoto J. Time-frequency analysis of tremors. Brain 1998; 121: 2127-34
67. Thompson PD, Colebatch JG, Brown P, et al. Voluntary stimulus-sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes. Mov Disord 1992; 7: 257-62
68. Brown P, Thompson PD. Electrophysiological aids to jerks, spasms and tremor. Mov Disord 2001; 16: 595-9
69. Garza JA, Louis ED, Ford B. Long-term outcome of psychogenic movement disorders. Neurology 2001; 56: A120
70. Thomas M, Jankovic J. Long term prognosis of patients with psychogenic movement disorders [abstract]. Neurology 2002; 58: A483
71. Reuber M, Pukrop R, Bauer J, et al. Outcome in psychogenic non epileptic seizures: 1 to 10 year follow up in 164 patients. Ann Neurol 2003; 53: 305-11
72. Stone J, Sharpe M, Rothwell P, et al. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2003; 74: 591-6
73. Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 2002; 167: 1253-60
74. Joffe R, Sokolov S, Streiner D. Antidepressant treatment of depression: a meta-analysis. Can J Psychiatry 1996; 41: 613-6
75. Moller HJ, Fuger J, Kasper S. Efficacy of new generation antidepressants: metaanalysis of imipramine-controlled studies. Pharmacopsychiatry 1994; 27: 215-23
76. Brawman-Mintzer O. Pharmacologic treatment of generalized anxiety disorder. Psychiatr Clin North Am 2001; 24: 119-37
77. Barsky AJ. The patient with hypochondriasis. N Engl J Med 2001; 345: 1395-9
78. Reich P, Gottfried LA. Factitious disorders in a teaching hospital. Ann Intern Med 1983; 99: 240-7
79. Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis: a randomized controlled trial. Br J Psychiatry 1998; 173: 218-25
80. Kroenke K, Swindle R. Cognitive behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000; 69: 205-15
81. Critchley HD, Melmed RN, Featherstone E, et al. Brain activity during biofeedback relaxation: a functional neuroimaging investigation. Brain 2001; 124: 1003-12
82. Brown RJ, Trimble MR. Dissociative psychopathology, non-epileptic seizures, and neurology. J Neurol Neurosurg Psychiatry 2000; 69: 285-91
83. Mailis-Gagnon A, Giannoylis I, Downar J, et al. Altered central somatosensory processing in chronic pain patients with "hysterical" anesthesia. Neurology 2003; 60: 1501-7